Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F–FDG PET/CT, predict the recurrence of endometrial cancer
Version of Record online: 8 JAN 2014
© 2014 Royal College of Obstetricians and Gynaecologists
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 121, Issue 9, pages 1097–1106, August 2014
How to Cite
Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F–FDG PET/CT, predict the recurrence of endometrial cancer. BJOG 2014;121:1097–1107., , , , , , , , , .
- Issue online: 22 JUL 2014
- Version of Record online: 8 JAN 2014
- Manuscript Accepted: 24 SEP 2013
|bjo12543-sup-0001-FigS1.pdf||application/PDF||335K||Figure S1. Kaplan–Meier plots of the overall survival rates of 84 patients with endometrial cancer who underwent preoperative PET/CT.|
|bjo12543-sup-0002-TableS1.doc||Word document||95K||Table S1. Comparison of the clinicopathological characteristics between the groups according to preoperative PET/CT.|
|bjo12543-sup-0003-TableS2.doc||Word document||59K||Table S2. Univariate analysis of the prognostic factors associated with overall survival.|
|bjo12543-sup-0004-TableS3.doc||Word document||42K||Table S3. Comparison of the SUVmax, MTV, and TLG values of the primary tumours according to the patient body mass index.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.